Intensity Therapeutics Inc. Watch

from 8-K 33 pages Securities Purchase Agreement

from 10-Q 17 pages Collaboration Agreement Between Intensity Therapeutics 1 Enterprise Drive, Suite 430, Shelton Ct 06484; USA ("Intensity"). (Hereinafter “Partner”) and the Swiss Group for Clinical Cancer Research Sakk Effingerstrasse 33, Ch-Bern, 3008, Switzerland (Hereinafter “Sakk”) Partner and the Sakk Hereinafter Also Referred to as “Party” or Jointly “The Parties” Regarding

from 8-K 6 pages Plan Objective ● Reinforce Intensity’s Mission to Help Patients Live Longer, Higher Quality Lives by Discovering, Developing, and Commercializing First-In-Class Cancer Drugs That Attenuate Tumors With Minimal Side Effects, While Training the Patient’s Own Immune System to Fight the Cancer. ● Focus Efforts on Successful Execution of Critical Path Activities to Achieve Company Performance. ● Establish Strong Linkage Between Individual Performance, Key Results, and Compensation. ● Drive Collaboration Across All Objectives/Key Results, Optimizing Multi-Disciplinary Expertise and Cross-Functional Teamwork. ● Emphasize Leadership Accountability for Achievement of Company Milestones. Eligibility

from 8-K 10 pages Employment Agreement

from 8-K 44 pages Underwriting Agreement Between Intensity Therapeutics, Inc. and the Benchmark Company, LLC as Representative of the Several Underwriters Intensity Therapeutics, Inc. Underwriting Agreement

from S-1/A 8 pages Employment Agreement

from S-1/A 4 pages Lease Modification/Termination Agreement

from S-1/A 4 pages Second Amendment of Lease

from S-1/A 2 pages First Amendment of Lease

from S-1/A 25 pages Office Lease by and Between Waldman Associates Limited Partnership (Landlord) and Intensity Therapeutics, Inc. (Tenant) Dated: January 16, 2017

from S-1/A 8 pages Consulting Service Agreement

from S-1/A 14 pages Employment Agreement

from S-1/A 25 pages Intensity Therapeutics Inc. 2021 Stock Incentive Plan

from S-1/A 13 pages Indemnification Agreement

from S-1/A 17 pages [Certain Information in This Exhibit Identified by [***] Is Confidential and Has Been Excluded Because It (I) Is Not Material and (II) the Registrant Customarily and Actually Treats That Information as Private or Confidential.] Material Transfer and Collaboration Agreement

from S-1/A 15 pages Intensity Therapeutics, Inc. 2013 Stock and Option Plan Section 1 Title

from S-1 36 pages [Certain Information in This Exhibit Identified by [***] Is Confidential and Has Been Excluded Because It (I) Is Not Material and (II) the Registrant Customarily and Actually Treats That Information as Private or Confidential.] Clinical Trial Collaboration and Supply Agreement by and Between Msd International Gmbh, and Intensity Therapeutics, Inc. Dated: June 21, 2019

from S-1 45 pages [Certain Information in This Exhibit Identified by [***] Is Confidential and Has Been Excluded Because It (I) Is Not Material and (II) the Registrant Customarily and Actually Treats That Information as Private or Confidential.] Clinical Trial Collaboration and Supply Agreement

from S-1 8 pages Employment Agreement

from S-1 8 pages Employment Agreement